Todd Franklin Watanabe Insider Trading $ARQT Arcutis Biotherapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Todd Franklin Watanabe.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Todd Franklin Watanabe. Todd Franklin Watanabe is President and CEO in Arcutis Biotherapeutics, Inc. ($ARQT).
Todd Franklin Watanabe in Arcutis Biotherapeutics, Inc.
Trading Symbol: ARQTIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Todd Franklin Watanabe: President and CEO
Holdings: 594,523 shares
Latest Transaction: May 11 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Todd Franklin Watanabe in Arcutis Biotherapeutics, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 11 2021 | ARQT | Arcutis Biotherape ... | Watanabe Todd Franklin | President and CEO | Option Exercise | M | 1.68 | 750 | 1,260 | 133,135 | |
May 11 2021 | ARQT | Arcutis Biotherape ... | Watanabe Todd Franklin | President and CEO | Sell | S | 35.00 | 750 | 26,250 | 593,773 | 594.5 K to 593.8 K (-0.13 %) |
May 11 2021 | ARQT | Arcutis Biotherape ... | Watanabe Todd Franklin | President and CEO | Buy | M | 1.68 | 750 | 1,260 | 594,523 | 593.8 K to 594.5 K (+0.13 %) |
May 07 2021 | ARQT | Arcutis Biotherape ... | Watanabe Todd Franklin | President and CEO | Option Exercise | M | 1.68 | 1,607 | 2,701 | 133,885 | |
May 07 2021 | ARQT | Arcutis Biotherape ... | Watanabe Todd Franklin | President and CEO | Sell | S | 34.00 | 1,750 | 59,500 | 593,773 | 595.5 K to 593.8 K (-0.29 %) |
May 07 2021 | ARQT | Arcutis Biotherape ... | Watanabe Todd Franklin | President and CEO | Buy | M | 1.68 | 1,607 | 2,701 | 595,523 | 593.9 K to 595.5 K (+0.27 %) |
May 04 2021 | ARQT | Arcutis Biotherape ... | Watanabe Todd Franklin | President and CEO | Sell | S | 35.00 | 1,500 | 52,500 | 593,916 | 595.4 K to 593.9 K (-0.25 %) |
Apr 06 2021 | ARQT | Arcutis Biotherape ... | Watanabe Todd Franklin | President and CEO | Sell | S | 29.93 | 1,750 | 52,378 | 595,416 | 597.2 K to 595.4 K (-0.29 %) |
Mar 05 2021 | ARQT | Arcutis Biotherape ... | Watanabe Todd Franklin | President and CEO | Option Exercise | A | 32.44 | 99,200 | 3,218,048 | 99,200 | |
Mar 05 2021 | ARQT | Arcutis Biotherape ... | Watanabe Todd Franklin | President and CEO | Sell | S | 30.55 | 1,750 | 53,463 | 597,166 | 598.9 K to 597.2 K (-0.29 %) |
Mar 05 2021 | ARQT | Arcutis Biotherape ... | Watanabe Todd Franklin | President and CEO | Grant | A | 0.00 | 32,700 | 0 | 598,916 | 566.2 K to 598.9 K (+5.78 %) |
Mar 03 2021 | ARQT | Arcutis Biotherape ... | Watanabe Todd Franklin | President and CEO | Sell | S | 35.19 | 2,107 | 74,136 | 566,216 | 568.3 K to 566.2 K (-0.37 %) |
Mar 03 2021 | ARQT | Arcutis Biotherape ... | Watanabe Todd Franklin | President and CEO | Sell | S | 35.19 | 2,107 | 74,136 | 566,216 | 568.3 K to 566.2 K (-0.37 %) |
Feb 08 2021 | ARQT | Arcutis Biotherape ... | Watanabe Todd Franklin | President and CEO | Option Exercise | M | 1.68 | 10,000 | 16,806 | 135,492 | |
Feb 08 2021 | ARQT | Arcutis Biotherape ... | Watanabe Todd Franklin | President and CEO | Sell | S | 34.61 | 6,700 | 231,898 | 568,323 | 575 K to 568.3 K (-1.17 %) |
Feb 08 2021 | ARQT | Arcutis Biotherape ... | Watanabe Todd Franklin | President and CEO | Sell | S | 33.64 | 3,300 | 111,017 | 575,023 | 578.3 K to 575 K (-0.57 %) |
Feb 08 2021 | ARQT | Arcutis Biotherape ... | Watanabe Todd Franklin | President and CEO | Buy | M | 1.68 | 10,000 | 16,806 | 578,323 | 568.3 K to 578.3 K (+1.76 %) |
Jan 07 2021 | ARQT | Arcutis Biotherape ... | Watanabe Todd Franklin | President and CEO | Option Exercise | M | 1.68 | 3,000 | 5,042 | 155,492 | |
Jan 07 2021 | ARQT | Arcutis Biotherape ... | Watanabe Todd Franklin | President and CEO | Sell | S | 30.00 | 3,000 | 90,000 | 566,928 | 569.9 K to 566.9 K (-0.53 %) |
Jan 07 2021 | ARQT | Arcutis Biotherape ... | Watanabe Todd Franklin | President and CEO | Buy | M | 1.68 | 3,000 | 5,042 | 569,928 | 566.9 K to 569.9 K (+0.53 %) |
Oct 01 2020 | ARQT | Arcutis Biotherape ... | Watanabe Todd Franklin | President and CEO | Option Exercise | M | 1.68 | 3,000 | 5,042 | 155,492 | |
Oct 01 2020 | ARQT | Arcutis Biotherape ... | Watanabe Todd Franklin | President and CEO | Sell | S | 30.00 | 3,000 | 90,000 | 566,928 | 569.9 K to 566.9 K (-0.53 %) |
Oct 01 2020 | ARQT | Arcutis Biotherape ... | Watanabe Todd Franklin | President and CEO | Buy | M | 1.68 | 3,000 | 5,042 | 569,928 | 566.9 K to 569.9 K (+0.53 %) |
Mar 16 2020 | ARQT | Arcutis Biotherape ... | Watanabe Todd Franklin | President and CEO | Option Exercise | M | 1.68 | 59,481 | 99,964 | 158,492 | |
Mar 16 2020 | ARQT | Arcutis Biotherape ... | Watanabe Todd Franklin | President and CEO | Buy | M | 1.68 | 59,481 | 99,964 | 566,928 | 507.4 K to 566.9 K (+11.72 %) |
Mar 03 2020 | ARQT | Arcutis Biotherape ... | Watanabe Todd Franklin | President and CEO | Option Exercise | A | 27.61 | 65,000 | 1,794,650 | 65,000 | |
Mar 03 2020 | ARQT | Arcutis Biotherape ... | Watanabe Todd Franklin | President and CEO | Grant | A | 0.00 | 29,000 | 0 | 507,447 | 478.4 K to 507.4 K (+6.06 %) |
Page: 1